DowngradeThe rating has been downgraded to Underperform due to limited upside potential in the stock price while the acquisition by The Doctors Co. is pending regulatory approval.
Growth ChallengesProAssurance has been playing defense amidst a difficult market backdrop, struggling to grow due to strong competition.
ValuationPRA trades at a higher EPS multiple than peers with a lower return on equity, indicating less potential upside compared to other companies.